ca-rcpsc-im MCQ (SBA): Secondary prevention dyslipidaemia

Instant feedback + full explanation. One question, done properly.

HardCardiologySecondary prevention dyslipidaemiaca-rcpsc-im

A 71-year-old man with prior ST-elevation myocardial infarction treated with PCI 6 months ago is on high-intensity statin therapy. His repeat LDL cholesterol is 2.3 mmol/L. According to current CCS guidance on secondary prevention, what is the recommended LDL target or threshold at which to consider intensifying lipid-lowering therapy with a non-statin agent?

Educational content. Not a substitute for clinical judgement or local policy.

ca-rcpsc-im MCQ: Secondary prevention dyslipidaemia — Answer & Explana